Top Sell
Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Acadia Pharmaceuticals | 23 | 1 | 3 | 1 | €15.62 | €32.59 | 108.678% |
AEterna Zentaris Inc. | 3 | 20 | 0 | 2 | €1.86 | €14.02 | 653.790% |
Agenus Inc. | 2 | 3 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
Anavex Life Sciences Corp | 0 | 2 | 0 | 1 | €3.49 | - | - |
Applied Therapeutics Inc | 1 | 1 | 0 | 1 | €4.26 | €4.00 | -6.103% |
Arca Biopharma | 0 | 22 | 0 | 3 | €3.26 | - | - |
Arrowhead Pharmaceuticals Inc. | 12 | 2 | 0 | 0 | €21.76 | €47.88 | 120.046% |
Aspira Womens Health Inc. | 0 | 1 | 0 | 0 | €3.02 | - | - |
Atara Biotherapeutics Inc. | 2 | 3 | 0 | 0 | €0.63 | €3.00 | 379.386% |
Bayer AG ADR | 1 | 1 | 0 | 0 | €6.60 | €7.00 | 6.061% |
Bellicum Pharmaceuticals Inc. | 0 | 13 | 0 | 0 | €0.064 | - | - |
Biofrontera AG | 0 | 2 | 0 | 0 | €0.36 | €0.000 | -100.000% |
BioLine RX Ltd ADR | 0 | 2 | 0 | 0 | €0.65 | - | - |
Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.84 | €8.82 | 949.964% |
B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.76 | €30.00 | 986.957% |
Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €41.05 | €67.64 | 64.793% |
Carbylan Therapeutics Inc | 1 | 1 | 0 | 0 | €9.80 | €22.00 | 124.490% |
CEL-SCI Corp. | 0 | 6 | 0 | 0 | €1.31 | - | - |
Chimerix Inc. | 4 | 1 | 0 | 0 | €0.84 | €5.51 | 557.282% |
Coherus Bioscien. | 2 | 2 | 0 | 0 | €1.93 | €3.00 | 55.079% |
Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €36.20 | €50.00 | 38.122% |
Corvus Pharmaceuticals Inc | 4 | 1 | 0 | 1 | €1.42 | €5.10 | 259.866% |
Cyclacel Pharmaceuticals Inc. | 1 | 12 | 0 | 0 | €0.22 | €19.12 | 8591.136% |
Cytomx Therapeutics Inc | 2 | 1 | 2 | 1 | €4.25 | €50.00 | 1076.471% |
CytoTools AG | 0 | 1 | 0 | 0 | €0.51 | - | - |